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The transcription factorBcl6 is essential for thedevel-
opment of germinal center (GC) B cells and follicular
helper T (Tfh) cells. However, little is known about
in vivo dynamics of Bcl6 protein expression during
and after development of these cells. By using
a Bcl6 reporter mouse strain, we found that antigen-
engaged B cells upregulated Bcl6 before clustering
in GCs. Two-photon microscopic analysis indicated
that Bcl6 upregulation in pre-GC B cells contributed
to sustaining their interactions with helper T cells
and was required for their entry to GC clusters. Our
data also suggested that Tfh cells gradually downmo-
dulated Bcl6 protein over weeks after development.
TheBcl6-lowTfh cells rapidly terminatedproliferation
and upregulated IL-7 receptor. These results clarify
the role of Bcl6 in pre-GC B cell dynamics and high-
light the modulation of Bcl6 expression in Tfh cells
thatpersist in the latephaseof theantibody response.
INTRODUCTION
The germinal center (GC) is the important microstructure formed
in the B cell follicle of the secondary lymphoid organs for
producing long-term, high-affinity antibody (Ab) responses (Ma-
cLennan, 1994). In most Ab responses against protein antigens
(Ags), GC B cells, which are characterized by the GL7hi, Fashi,
CD38lo (in mice), and IgDlo surface phenotype, are dependent
on help provided by CD4+ T cells for their development, mainte-
nance, and possibly the selection (Allen et al., 2007a; Kurosaki
et al., 2010; Victora et al., 2010; Vinuesa et al., 2010). Helper
T cells residing in the B cell follicles and GCs are named follicular
helper T (Tfh) cells and highly express surface moleculesincluding CXCR5 and PD-1 and the cytokines IL-21 and IL-4
(Allen et al., 2007a; Good-Jacobson et al., 2010; Vinuesa et al.,
2010). The generation of Tfh cells usually requires interactions
of CD4+ T cells with cognate Ag-engaged B cells, dynamics of
which is featured by sustained conjugation of these cells, and
in turn, is essential for GC B cell development and/or mainte-
nance (Crotty et al., 2010; Linterman and Vinuesa, 2010).
The transcription factor Bcl6was discovered to be essential for
the GC formation more than a decade ago (Dent et al., 1997;
Fukudaet al., 1997;Ye et al., 1997). Bcl6protein is abundantly ex-
pressed inGCBcells compared tonaiveBcells, andBcells intrin-
sically require Bcl6 for their development into GC B cells (Crotty
et al., 2010; Klein and Dalla-Favera, 2008; Nurieva et al., 2009;
Shaffer et al., 2001; Yu et al., 2009). Bcl6 can repress a number
of target genes and has various functions in GC B cell biology
including protection from DNA damage-induced apoptosis and
inhibition of differentiation to plasma cells or memory cells (Klein
and Dalla-Favera, 2008). Bcl6 expression also modulates costi-
mulatory signals relevant in interactions with helper T cells (Klein
and Dalla-Favera, 2008). However, it is not known whether Bcl6
expression can modulate B cell-T cell interaction dynamics. In
addition, Bcl6 has been suggested to be important for the GC
B cell localization. Bcl6 represses expression of Gpr183, encod-
ing a G protein-coupled receptor EBI-2 (Shaffer et al., 2001). Up-
regulation and downregulation of EBI-2 have been shown to be
important for the localization of Ag-engaged B cells in the outer
follicle region and subsequent clustering of GCB cells in the inner
region of the follicle, respectively (Gatto et al., 2009; Pereira et al.,
2009). Thus, it has been suggested that Bcl6 controls GC B cell
positioning via this pathway (Chan et al., 2010; Pereira et al.,
2010). However, whether Bcl6 upregulation in B cells begins in
the outer follicle to drive them to cluster in GCs or it occurs in
B cells that have briefly accessed the inner follicle to retain
them in the region remains to be clarified.
Recently, Tfh cell development was also found to be strictly
dependent on Bcl6 (Johnston et al., 2009; Nurieva et al., 2009;
Yu et al., 2009). CD4+ T cells modestly upregulate Bcl6Immunity 34, 961–972, June 24, 2011 ª2011 Elsevier Inc. 961
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Figure 1. Characterization of Bcl6yfp Mice
(A) Flow cytometry of PP cells from Bcl6yfp/+ mice.
Shaded histograms show Bcl6+/+ control cells.
(B) Immunoblot analysis of Bcl6 and YFP-Bcl6
protein expression in GC B cells, naive B cells, Tfh
cells, and naive CD4+ T cells of the indicated
genotypes.
(C) Intracellular Bcl6 staining signals (ic Bcl6) in PP
cells from Bcl6yfp/+ mice and Bcl6+/+ mice were
analyzed. Note that YFP-Bcl6 fluorescence was
slightly reduced by cell fixation. The numbers
show the percentages of cells in the gates.
Immunity
Bcl6 Protein Dynamics during the Antibody Responsetranscripts through interactions with non-B cell Ag-presenting
cells, presumably dendritic cells (Poholek et al., 2010). CD4+
T cells further upregulate Bcl6 expression through sustained
cognate interactions with B cells, which is important for Tfh
cell development (Crotty et al., 2010; Deenick et al., 2010; Linter-
man and Vinuesa, 2010; Poholek et al., 2010). Although expres-
sion of Bcl6 transcripts in CD4+ T cells has been analyzed in the
various settings of immune responses, dynamics of Bcl6 protein
expression during the Tfh cell development still need to be
understood because Bcl6 mRNA quantities are in some cases
a poor indicator of Bcl6 protein expression (Crotty et al., 2010;
Klein and Dalla-Favera, 2008). Moreover, little is known about
the stability of Bcl6 expression in Tfh cells after their develop-
ment despite its potential importance in their fate decision.
In order to understand Bcl6 expression dynamics in B cells
and helper T cells during the Ab response and to address the
questions raised above, we developed a reporter mouse strain
to track Bcl6 protein expression in vivo. By utilizing the reporter
mouse we provide evidence that Bcl6 upregulation of B cells in
the outer follicle sustains their interactions with helper T cells
and allows them to enter the GC region. Our results also highlight
the Tfh cell heterogeneity in Bcl6 protein expression and suggest
that tuning of Bcl6 expression is linked to the regulation of Tfh
cell proliferation and gene expression pertaining to their homeo-
static cytokine responsiveness and migration potential.
RESULTS
Generation and Characterization of the Bcl6yfp Mice
To analyze Bcl6 protein expression in vivo, we generated
a reporter mouse strain by gene targeting. The monomeric962 Immunity 34, 961–972, June 24, 2011 ª2011 Elsevier Inc.yellow fluorescent protein (YFP) gene
was inserted in-frame right after the initia-
tion codon of the Bcl6 gene such that the
product of this allele would be the YFP-
Bcl6 fusion protein (Figure S1A available
online). Flow cytometric analysis of
Peyer’s patch (PP) cells from heterozy-
gous mice detected substantial YFP
signals in more than 90% of GC B cells
and weak YFP signals in non-GC B cells
(Figure 1A). Within CD4+ T cells, YFP
signals were selectively found in the
CXCR5hiPD-1hi Tfh cell population
although these cells appeared to bemore heterogeneous in YFP expression than GC B cells (Fig-
ure 1A). Even Tfh cells with the highest CXCR5 and PD-1 expres-
sion were found to be heterogeneous in YFP-Bcl6 expression
(Figure S1B). Immunoblot analysis of sorted Bcl6+/+ GC B cells
with anti-Bcl6 detected a protein of the Bcl6 size (79 kDa), which
appeared to be far more abundant in GC B cells than in naive
B cells (Figure 1B) andwasundetectable inBcl6yfp/yfp naiveB cells
(Figure S1C). In addition to this protein, the Ab detected another
protein of the YFP-Bcl6 size (107 kDa) in Bcl6yfp/+ GC B cells,
but not in Bcl6+/+ GC B cells. Importantly, heterozygous cells ex-
pressed similar amounts of these two anti-Bcl6-reactive proteins
given that the YFP-Bcl6 band intensity was 115% ± 7.52% for
Bcl6yfp/+ B cells (mean ± SEM, n = 3) and 103% ± 17.7% for
Bcl6yfp/+ Tfh cells (n = 4) of the Bcl6 band intensity. The amount
of Bcl6 produced by the wild-type allele of heterozygous cells
was 69.6% ± 9.25% (Bcl6yfp/+ B cells, n = 3) and 62.5% ±
19.6% (Bcl6yfp/+ Tfh cells, n = 4) of the Bcl6 amount in wild-type
B cells and Tfh cells, respectively. We also performed intracellular
staining with anti-Bcl6 for flow cytometry, and found that the YFP
signals were well correlated with the intracellular staining signals
both in GC B cells and Tfh cells (Figure 1C). Thus, the YFP signal
derived from the Bcl6yfp allele of heterozygous mice serves as
a reliable reporter for Bcl6 protein expression.
Whereas GC B cells and Tfh cells in Bcl6yfp/+ mice were not
significantly decreased compared to wild-type mice, Bcl6yfp/yfp
mice had reduced numbers of GC B cells and Tfh cells in PPs
(Figure S1D). These results indicate that YFP fusion near the N
terminus compromised Bcl6 function, although Bcl6yfp/yfp mice
are healthy unlike Bcl6-deficient mice (Dent et al., 1997; Fukuda
et al., 1997; Ye et al., 1997). However, serum immunoglobulin
titers of the isotypes tested were not significantly altered in
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Figure 2. Kinetics of YFP-Bcl6 Expression in Ag-Engaged B Cells and Helper T Cells
(A and B) Representative flow cytometry plots of adoptively transferred Bcl6yfp/+ Hy10 B cells (A) and Bcl6yfp/+OT-II T cells (B) in draining LNs after immunization
with HEL-OVA in CFA. In themiddle row, YFPhi Hy10 B cells and YFP+OT-II T cells (gated in the top row) were shown as green dots. In the bottom row, histograms
show YFP-Bcl6 expression in totalBcl6yfp/+Hy10 B cells, FashiCD38lo Hy10 B cells (gated in the middle row), totalBcl6yfp/+OT-II T cells, and CXCR5hiPD-1hi OT-II
T cells (gated in the middle row).
(C and D) Enumeration of the Bcl6yfp/+Hy10 B cell populations (C) and the Bcl6yfp/+OT-II T cell populations (D). The symbol color corresponds to the gate color in
(A) and (B). The percentages were calculated from data containing at least 10 cells for the denominator. Each symbol object represents a data of a LN, and bars
show averaged values. Data are of six LNs (day 0) and 12 LNs (days 2–10) from three mice for each time point in two independent experiments. GMFI, geometric
mean fluorescent intensity.
Immunity
Bcl6 Protein Dynamics during the Antibody ResponseBcl6yfp/+ mice or Bcl6yfp/yfp mice, suggesting that Ab class-
switching is not affected by the Bcl6yfp allele (Figure S1E).
Kinetics of Bcl6 Protein Expression in Ag-Engaged
B Cells and CD4+ T Cells
To track Bcl6 expression in Ag-engaged B cells and CD4+
T cells, we crossed Bcl6yfp mice to avian lysozyme-specific
Hy10 (aka VDJ9/k5) B cell receptor (BCR) gene-targeted trans-
genic mice (Allen et al., 2007b) or to OT-II T cell receptor (TCR)
transgenic mice. Bcl6yfp/+ Hy10 B cells and Bcl6yfp/+ OT-II
CD4+ T cells were cotransferred into congenic recipients, which
subsequently received s.c. immunization with hen egg lysozyme
(HEL)-ovalbumin (OVA)-conjugated protein. In the draining
lymph nodes (LNs), YFP-Bcl6 upregulation began to be detected
in someHy10 B cells on day 3 of immunization (mice were immu-
nized on day 0), and on day 4, Hy10 B cells were separated into
two distinct populations of YFPhi cells and YFPlo cells (Figure 2A).The percentage of YFPhi cells in Hy10 B cells reached a plateau
on day 5, although absolute numbers of Hy10 B cells decreased
between days 5 and 10.Majority of YFPhi Hy10B cells fell into the
FashiCD38lo population by day 5. Upregulation of Fas and GL7
preceded Bcl6 upregulation, which was closely followed by
CD38 downregulation (Figures 2A and 2C). In OT-II T cells
YFP-Bcl6 expression was substantially upregulated by day 2,
reached a maximum at approximately day 3, and then
decreased toward day 10 (Figures 2B and 2D). After day 3,
a majority of the YFP+ OT-II T cells were CXCR5hiPD-1hi. The
percentage of CXCR5hiPD-1hi cells in OT-II T cells reached
a maximum between days 3 and 4. Interestingly, not only YFP-
Bcl6 expression in total OT-II T cells but also that in the
CXCR5hiPD-1hi cell population decreased after day 3 (Figures
2B and 2D). Three weeks after immunization, most if not all of
CXCR5hiPD-1hi OT-II T cells became YFP low or negative (Fig-
ure S2A). Consistent with the PP cell analysis in Figure 1C,Immunity 34, 961–972, June 24, 2011 ª2011 Elsevier Inc. 963
Immunity
Bcl6 Protein Dynamics during the Antibody ResponseYFP-Bcl6 signals were well correlated with intracellular Bcl6
staining signals in Bcl6yfp/+ Hy10 B cells and Bcl6yfp/+ OT-II
T cells (Figure S2B). Because Bcl6 is known to promote Tfh
cell formation in a gene dose-dependent manner (Yu et al.,
2009), we examined whether Bcl6yfp/+ Tfh cells show abnormal-
ities in formation kinetics or gene expression. As shown in Fig-
ure S2C, Bcl6+/+ OT-II T cells and Bcl6yfp/+ OT-II T cells formed
similar numbers of Tfh cells at time points tested. In addition,
Tfh cell-related gene expression was indistinguishable between
Bcl6+/+ OT-II Tfh cells and Bcl6yfp/+ OT-II Tfh cells (Figures S2D
and S2E). Intracellular Bcl6 staining of Bcl6+/+ Hy10 B cells and
Bcl6+/+ OT-II T cells confirmed induction kinetics of Bcl6 re-
vealed by use of Bcl6yfp/+ cells (Figure S2F). Importantly, reduc-
tion of intracellular Bcl6 signals in Bcl6+/+OT-II Tfh cells was also
observed between days 3 and 10 (Figure S2G). These results
indicate that upregulation of Bcl6 protein in Ag-engaged CD4+
T cells precedes that in Ag-engaged B cells. They also strongly
suggest that after development of Tfh cells, which has been
shown to require Bcl6, Bcl6 protein is gradually downmodulated
in Tfh cells, whereas Bcl6 protein expression in GC B cells
continues to be more uniformly high after development.
Ag-Engaged B Cells Upregulate Bcl6 Prior to Clustering
in GCs
To understand where in the tissue Ag-engaged B cells and CD4+
T cells upregulate Bcl6, we performed immunofluorescence
staining of LN sections. Because YFP-Bcl6 fluorescence was
not strong enough for histological analysis, we used polyclonal
anti-green fluorescent protein (GFP) to detect YFP-Bcl6 expres-
sion in adoptively transferred avian lysozyme-specific MD4
BCR-transgenic B cells and OT-II T cells. We used MD4 B cells
rather than Hy10 B cells for the technical simplicity of multistain-
ing of LN sections with anti-IgMa and anti-CD45.2. Unlike Hy10
B cells, MD4 B cells are not able to undergo class-switch
recombination or somatic hypermutation in their transgenic
BCR gene. Nonetheless, the previous studies suggest that
MD4 B cells perform as a good model system for analysis of
cell localization during the early phase of responses including
clustering in GCs (Okada et al., 2005). Although the staining
with anti-GFP produced background signals on some tissue
structures, nuclear YFP-Bcl6 signals were convincingly de-
tected in transferred Bcl6yfp/+ cells, but not in Bcl6+/+ cells,
most prominently in the GC clusters (Figure 3A). When we
analyzed LN sections of the day 3 time point, we noticed that
MD4 B cells had not formed GC clusters in many follicles and
were located mostly in the outer follicle, including interfollicular
regions as previously described (Pereira et al., 2010). We de-
tected YFP-Bcl6 expression in some of MD4 B cells in the outer
follicle (Figures 3B and 3C), although the percentage of YFP+
cells in MD4 B cells was variable among individual follicles at
this time point, ranging from less than 10% to over 60%.
Thus, Ag-engaged B cells upregulate Bcl6 in the outer follicle
before forming GC clusters.
B-T Cell Interaction Requirements in Bcl6 Upregulation
in Ag-Engaged CD4+ T Cells and B Cells
On day 3, substantial numbers of OT-II T cells were found in the
follicular regions, particularly in the outer follicle and interfollicu-
lar regions.Many of these cells in the follicular regions expressed964 Immunity 34, 961–972, June 24, 2011 ª2011 Elsevier Inc.YFP-Bcl6 (Figures 3B and 3D). OT-II T cells in the T cell zone ap-
peared to be largely YFP negative. Nonetheless, YFP-Bcl6
expression, although usually weaker than that in OT-II T cells in
the follicle, was detected in a small fraction of these cells in the
T cell zone (Figures 3B and 3E), suggesting that Bcl6 protein
expression by CD4+ T cells might start in the T cell zone before
cognate interactions with B cells. To test this, we transferred
Bcl6yfp/+ OT-II T cells to B cell-deficient mice. Consistent with
previous studies (Haynes et al., 2007; Johnston et al., 2009; Po-
holek et al., 2010), Tfh cell development was severely compro-
mised in B cell-deficient mice (Figure S3A). On day 5, we
detected YFP-Bcl6 expression in transferred cells in the B cell-
deficient recipients, but the maximum degrees of YFP-Bcl6
expressed in these cells were significantly decreased compared
to Bcl6yfp/+ OT-II T cells transferred to wild-type recipients. By
day 10, YFP+ OT-II T cells in B cell-deficient recipients became
almost undetectable (Figure S3B). These results support that
Ag-engaged CD4+ T cells begin Bcl6 protein expression in the
T cell zone and further increase it through interactions with Ag-
presenting B cells to become Tfh cells.
We also performed the converse experiment to assess the
impact of T cell deficiency on Bcl6 upregulation in B cells.
B1-8hi BCR gene targeted transgenic B cells specific for
4-hydroxy-3-nitrophenyl acetyl (NP) (Shih et al., 2002) were
transferred to wild-type or TCR-a-deficient mice immunized
with NP-OVA. Bcl6yfp/+ B1-8hi B cells transferred to wild-type
recipients contained significant numbers of YFP-Bcl6hi cells on
days 5 and 10, whereas YFP-Bcl6hi cells were few (day 5) or
undetectable (day 10) in TCRa-deficient mice. In contrast,
when recipients were immunized with thymus-independent
type 2 Ag, NP-Ficoll, YFP-Bcl6hi cells were induced both in
wild-type mice and TCRa-deficient mice on day 5, but disap-
peared by day 10 (Figure S3C). These results are consistent
with the previous studies on GC B cell formation (Vinuesa
et al., 2010) and support the idea that T cell help is important
for initial Bcl6 upregulation in B cells when Ag valency is relatively
low and that sustainment of Bcl6hi GC B cells absolutely requires
T cell help regardless of Ag valency.
Hypomorphism of Bcl6yfp/yfp B Cells and Bcl6yfp/yfp CD4+
T Cells
To establish an experimental system to examine the role of Bcl6
upregulation in pre-GC B cell dynamics, we analyzed Bcl6yfp/yfp
MD4 B cells. As expected from the results described above (Fig-
ure S1D), Bcl6yfp/yfp MD4 B cells, which had been cotransferred
with Bcl6+/+ OT-II T cells into wild-type recipients immunized
with HEL-OVA, were severely impaired in the formation of the
FashiCD38lo GC B cell population compared to Bcl6yfp/+ MD4
B cells (Figure 4A). Interestingly, the YFPhi population of
Bcl6yfp/yfp MD4 B cells was nearly abolished (Figure 4A), sug-
gesting that YFP-Bcl6 is impaired in promoting survival of B cells
committed into the GC pathway. Indeed, the percentage of
annexin V+ cells in YFPhi Bcl6yfp/yfp B cells (12 ± 0.82%, n = 3),
although we could analyze only small numbers of these cells,
was significantly higher than in YFPhi Bcl6yfp/+ B cells (6.25% ±
1.47%, n = 3, p = 0.022). After 4 days of immunization, Bcl6yfp/yfp
MD4 B cells expressing GFP were observed to be unable to
accumulate in GCs, whereas GFP+ Bcl6+/+ MD4 B cells effi-
ciently did so (Figure 4B). These results confirm that Bcl6yfp/yfp
B
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Figure 3. Detection of YFP-Bcl6 in Pre-GC B Cells and Helper T Cells
Bcl6yfp/+ orBcl6+/+MD4Bcells andBcl6yfp/+ orBcl6+/+OT-II T cells were transferred to CD45.1 congenicmice, and immunizedwith HEL-OVA in CFA. LN sections
were stained with anti-GFP to detect YFP-Bcl6, for IgMa to identify MD4 B cells, and for CD45.2 to identify OT-II T cells andMD4 B cells. The scale bar represents
50 mm (A and B) and 5 mm (C–E).
(A) GCs formed on day 4 are shown at two different magnifications.
(B) YFP-Bcl6-expressing MD4 B cells and OT-II T cells on day 3 are marked by filled and open arrowheads, respectively. The dotted line shows approximate
location of the boundary between the B cell follicle and the T cell zone.
(C–E) Representative images of MD4 B cells and OT-II T cells on day 3. In (E), cells with weak but detectable YFP signals are marked with asterisks.
Immunity
Bcl6 Protein Dynamics during the Antibody ResponseMD4 B cells are useful for functional analysis of Bcl6 upregula-
tion in terms of B cell dynamics.
We also found thatBcl6yfp/yfpOT-II T cells were defective in the
formation of the cells with the highest expression of CXCR5 and
PD-1 (Figure 4A). Two-photon microscopy of LNs and subse-
quent flow cytometric analysis of the same LNs showed that
Bcl6yfp/yfp OT-II T cells expressing cyan fluorescent protein
(CFP) were reduced in the follicular mantle zone and more
severely in the GCs compared to GFP+ Bcl6+/+ or CFP+ Bcl6+/+
OT-II T cells (Figures 4C and 4D, and Movie S1). These results
support that Tfh cells with the highest expression of CXCR5
and PD-1 are the Tfh cell population inhabiting GCs. In addition,we examined the capacity of Bcl6yfp/yfp OT-II T cells to support
GC B cell development by cotransfer of purified Bcl6yfp/+ Hy10
B cells with Bcl6+/+ or Bcl6yfp/yfp OT-II T cells into Bcl6+/+ or
Bcl6yfp/yfp recipients. The number of YFPhi Hy10 GC B cells
was decreased when cognate helper T cells were of the
Bcl6yfp/yfp genotype (Figure S4A). Conversely, we also analyzed
Bcl6yfp/+ OT-II T cells that had been purified and transferred
into wild-type or Bcl6yfp/yfp recipients. Endogenous B cells in
Bcl6yfp/yfp recipient mice failed to develop GC B cells as ex-
pected. However, this near complete absence of GC B cells
did not significantly affect YFP-Bcl6 upregulation in or the
Tfh cell formation from transferred Bcl6yfp/+ OT-II T cellsImmunity 34, 961–972, June 24, 2011 ª2011 Elsevier Inc. 965
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Figure 4. Bcl6yfp/yfp B and T Cells Show Hypomorphic Phenotypes
(A) Flow cytometric analysis of transferred Bcl6yfp/+ or Bcl6yfp/yfp MD4 B cells and Bcl6yfp/+ or Bcl6yfp/yfp OT-II T cells in the draining LNs on day 7.
(B) Two-photon images of GCs in intact LNs. CFP+ Bcl6+/+ MD4 cells, GFP+ Bcl6+/+, or GFP+ Bcl6yfp/yfp B cells, and rhodamine-labeled polyclonal B cells were
transferred and visualized 4.5 days after immunization with HEL-OVA in alum. The images are 45 mm z projections. The scale bar represents 50 mm.
(C) Two-photon imaging of a GC in an intact LN on day 7 after immunization with NP-OVA in alum (see also Movie S1). CFP+ Bcl6yfp/yfp (C) or CFP+ Bcl6+/+ (not
shown) OT-II T cells, GFP+ Bcl6+/+ OT-II T cells, and rhodamine-labeled polyclonal B cells were cotransferred and visualized in recipient LNs. The image is
a 105 mm z projection. FM: follicular mantle. The scale bar represents 50 mm.
(D) Relative frequencies of Bcl6+/+OT-II T cells and Bcl6yfp/yfpOT-II T cells in the FM and GC. CFP+Bcl6yfp/yfp or CFP+Bcl6+/+OT-II T cells and GFP+Bcl6+/+OT-II
T cells located in the FM and GC regions were counted in two-photon images of LNs including (C), and the percentage of CFP+ cells within total OT-II T cells was
calculated. Cells from the same LNs were subsequently analyzed by flow cytometry, and the percentage of CFP+ cells in the total OT-II T cells in the LNs was
calculated. Data represent mean ± SEM.
The data are representative (A–C) or accumulation (D) of more than three experiments.
Immunity
Bcl6 Protein Dynamics during the Antibody Response(Figures S4B andS4C). These results suggest that the generation
or maintenance of Tfh cells, at least in the early phase of the Ab
response, does not depend on their interactions with GC B cells,
whereas GC B cell development is sensitive to the number of Tfh
cells with the highest CXCR5 and PD-1 expression.
Bcl6 Upregulation Is Essential for Entry of Pre-GC B
Cells to GC Clusters
Having established that Bcl6yfp/yfp MD4 B cells are severely
impaired in the formation of YFPhi GC B cells, we examined
whether the failure of these cells to be localized in GCs was
due to the blocked entry into the GC clusters. To test this possi-
bility, we used a protocol modified from the previous study that
reported entry of newly activated B cells into preformed GCs
(Schwickert et al., 2009). Two-photon imaging was performed
for the LNs in which CFP+ Bcl6+/+ MD4 B cells had already
formed GC clusters, whereas the majority of GFP+ Bcl6+/+ or
GFP+Bcl6yfp/yfpMD4B cells were still in the outer follicle regions.
During the 1 hr imaging period, a fraction of GFP+ Bcl6+/+MD4 B
cells were observed to enter the GC area demarcated by CFP
(Figures 5A– 5C; Movie S2 and Movie S3). Egress of these cells
from the GC area was less efficient than entry to the GC (Fig-966 Immunity 34, 961–972, June 24, 2011 ª2011 Elsevier Inc.ure 5C), confirming that these cells were in the course of clus-
tering into the GC. Remarkably, entry of GFP+ Bcl6yfp/yfp MD4
B cells to the GC area was severely impaired, although these
cells could access to the border of GCs (Figures 5A–5C; Movie
S2 and Movie S3). The number of GFP+ Bcl6yfp/yfp MD4 B cells
in the GC area was too small to determine the egress efficiency
from the GC. CXCR5 expression was not significantly different
between Bcl6yfp/+ B cells, Bcl6yfp/yfp B cells, and Bcl6+/+ B cells
(Figure S5A and data not shown). GC B cells are known to upre-
gulate CXCR4 (Allen et al., 2004), and this upregulation was
impaired in YFPhi Bcl6yfp/yfp B cells (Figure S5A). Importantly,
Gpr183 expression on day 3.5 was already downregulated in
Bcl6yfp/+ MD4 B cells after YFP-Bcl6 upregulation but not in
Bcl6yfp/yfp MD4 B cells (Figures S5B and S5C). These observa-
tions strongly suggest that Bcl6 upregulation in B cells in the
outer follicle enables these cells to migrate into GC clusters.
A Role for Bcl6 in B Cells in Sustaining Conjugation
with Helper T Cells
We also examined whether Bcl6 upregulation has impacts on
dynamics of B cell-T cell interactions by tracking contacts
between Bcl6+/+ or Bcl6yfp/yfp MD4 B cells and OT-II T cells in
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Figure 5. Bcl6yfp/yfp B Cells Are Defective in Entry to GCs and Stable B Cell-T Cell Interaction
(A) Two-photon imaging of the B cell entry into the pre-formed GC.Mice co-transferred with CFP+MD4B cells and OT-II T cells were immunized with HEL-OVA in
alum. After 36 hr, GFP+ Bcl6+/+ or GFP+ Bcl6yfp/yfp MD4 B cells were cotransferred with rhodamine-loaded polyclonal B cells into the immunized mice. The
draining LNs were subjected to imaging 3.5 days after the second transfer (see also Movie S2). The top panels are representative images from 60min recordings.
The bottom panels show the surface of GCs reconstructed from the CFP images and the trajectories of GFP+ MD4 B cells. The images are 30 mm z projections.
The scale bar represents 50 mm.
(B) Time-lapse images of a GFP+ Bcl6+/+MD4 B cell and a Bcl6yfp/yfpMD4 B cell accessing the GC border. Arrowheads in the far left panels indicate the tracked
MD4 B cells (see also Movie S3). Images are presented as 18 mm z projections; elapsed time is presented as mm:ss. The scale bar represents 50 mm.
(C) Relative frequency of the GFP+ Bcl6+/+MD4 B cell and Bcl6yfp/yfpMD4 B cell entry to and egress from GCs. The percentages of entering (or egressing) cells in
cells that accessed the GC border from the outside (or inside) of GCs and left the border in either way are shown as the entry (or egress) frequency (mean ± SEM,
n = 3 LNs, 69 and 58 total events scored in Bcl6+/+ and Bcl6yfp/yfp B cell entry analysis, respectively, and 44 total events scored in Bcl6+/+ B cell egress analysis).
N.D., not determined.
(D) Two-photon imaging of the B cell-T cell interaction. GFP+ Bcl6+/+MD4 B cells or GFP+ Bcl6yfp/yfpMD4 B cells were cotransferred with CFP+ OT-II T cells, and
recipients were immunized with HEL-OVA in alum. On day 3, the draining LNs were subjected to imaging. Fluorescence images and representative OT-II T cell
tracks were shown. While on the yellow and pink tracks, OT-II T cells were observed to interact with MD4 B cells for 6–15 min and for more than 15 min,
respectively (see also Movie S4). The scale bar represents 50 mm.
(E) Duration of contacts between Bcl6+/+ or Bcl6yfp/yfpMD4 B cells and OT-II T cells at the indicated time points (mean ± SEM, n = 4 for day 1 and n = 5 for day 3;
119 and 78 contacts for day 1, and 866 and 845 contacts for day 3 scored for Bcl6+/+ and Bcl6yfp/yfp B cells, respectively).
Immunity
Bcl6 Protein Dynamics during the Antibody Responsethe LNs (Figure 5D and Movie S4). We categorized the contacts
into three groups in terms of the contact time: shorter than 6min,
6 to 15 min, and longer than 15 min, on the basis of the previous
findings that noncognate B cell-T cell contacts hardly last more
than 6 min and that cognate interactions can be sustained for
more than 15 min in a signaling lymphocytic activation molecule(SLAM) family protein-dependent manner (Cannons et al., 2010;
Okada et al., 2005; Qi et al., 2008). One day after immunization,
the contact time for Bcl6yfp/yfp MD4 B cells was not significantly
different from that for Bcl6+/+ MD4 B cells (Figure 5E, Figures
S5D and S5E, and Movie S5). However, 3 days after immuniza-
tion, when majority of both Bcl6+/+ MD4 B cells and Bcl6yfp/yfpImmunity 34, 961–972, June 24, 2011 ª2011 Elsevier Inc. 967
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Figure 6. Gene Expression Analysis of Bcl6-
Low Tfh Cells
TransferredBcl6yfp/+OT-II T cells were sorted from
draining LN cells 7 or 10 days after immunization
with NP-OVA in CFA. YFP+ Tfh cells, YFP Tfh
cells, and non-Tfh cells were examined for mRNA
expression by microarray analysis.
(A) Flow cytometry of OT-II T cells before and after
sorting.
(B) Heat-map of mRNA expression. Mean values
of microarray data for the Tfh cell types (n = 4),
non-Tfh cells (n = 3), and naive CD4+ T cells (n = 2)
are shown (see also Table S1).
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Bcl6 Protein Dynamics during the Antibody ResponseMD4 B cells were located in the outer follicle, the frequency of
contacts lasting more than 6 min was significantly lower for
Bcl6yfp/yfp MD4 B cells than Bcl6+/+ MD4 B cells (Figures 5D
and 5E, Figure S5E, and Movie S4). These data together with
the observation that Ag-engaged B cells began to upregulate
Bcl6 3 days after immunization (Figure 2 and Figure 3) suggest
that Bcl6 upregulation in Ag-engaged B cells contributes to
sustaining conjugation with helper T cells.
Bcl6-Low Tfh Cells Are Detectable in the GC
and Accelerated to Become Proliferatively Quiescent
and Express IL-7 Receptor
As our results suggesting that Tfh cells downmodulate Bcl6 after
their development were unexpected, we sought to understand
functional characteristics of these Bcl6-low Tfh cells. To this
end, we sorted YFP+ Tfh cells, YFP Tfh cells, and non-Tfh cells
derived from Bcl6yfp/+OT-II T cells (Figure 6A). The gene expres-968 Immunity 34, 961–972, June 24, 2011 ª2011 Elsevier Inc.sion profiles of these cells were investi-
gated by microarray analysis (Figure 6B
and Table S1). The overall gene expres-
sion pattern of YFP- Tfh cells was much
closer to that of YFP+ Tfh cells than that
of non-Tfh cells (Figure S6). The most
striking difference between YFP+ Tfh
cells and YFP Tfh cells was that expres-
sion of geneswhose upregulation is asso-
ciated with cell cycle progression was
decreased in YFP- Tfh cells (Figure 6B
and Table S1). Indeed, DNA content anal-
ysis revealed that proliferation of YFP
Tfh cells was more rapidly decreased
than that of YFP+ Tfh cells between
days 4 and 7 (Figure 7A). Surprisingly,
mRNA expression of the transcription
factors important for helper T cell dif-
ferentiation was not much changed
between the two Tfh cell types: Bcl6
mRNA remained abundant in YFP Tfh
cells although slightly reduced com-
pared to YFP+ Tfh cells; expression of
Tbx21 (T-bet), Rorc (RORgt), and Prdm1
(Blimp-1) that Bcl6 can repress was
similarly low in the both Tfh cell types.
Expression of Bach2 encoding anotherrepressor of Prdm1 expression in B cells (Martins and Calame,
2008) was higher in YFP Tfh cells than in YFP+ Tfh cells. The
other Tfh-related genes, including Cxcr5, Pdcd1 (PD-1), Il4,
and Il21, were highly expressed in the both Tfh cell types
compared to non-Tfh cells or naive cells. Interestingly, transcripts
of Il7r, Ccr7, S1pr1 (sphingoshin-1-phosphate receptor-1), and
Klf2 (Kruppel-like factor 2, a transcription factor critical for
S1pr1 expression) (Carlson et al., 2006) were modestly but
noticeably upregulated in YFP- Tfh cells compared to YFP+ Tfh
cells (Figure 6B and Table S1).
Relatively higher surface expression of the IL-7 receptor alpha
chain (CD127) in YFP Tfh cells compared to YFP+ Tfh cells was
observed for OT-II Tfh cells (Figure 7B), and also for endogenous
Tfh cells in spleen (Figure S7A) and PPs (data not shown). Three
weeks after immunization, the majority of Bcl6yfp/+OT-II Tfh cells
(58% ± 4.0%, n = 3) orBcl6+/+OT-II Tfh cells (56% ± 7.6%, n = 3)
were CD127 positive. Intracellular Bcl6 staining of both Bcl6+/+
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Figure 7. Bcl6-Low Tfh Cells Are Detectable in the GC and Accelerated to Become Proliferatively Quiescent, and Express IL-7 Receptor
(A) Cell cycle analysis of YFP+ Tfh and YFP- Tfh cells. Mice transferred with Bcl6yfp/+OT-II cells were immunized with NP-OVA in CFA. On day 4 or day 7, draining
LN cells were stained with 4’6-diamidino-2-phenylindole (DAPI) and the Abs against the Tfh surface markers. Representative histograms and the percentage of
cells in the S and G2/M phases within YFP+ or YFP- Tfh cells are shown (mean ± SEM, n = 4).
(B) Flow cytometric analysis of CD127 andBcl6 expression inBcl6yfp/+OT-II Tfh cells andBcl6+/+OT-II Tfh cells on day 9 of i.p. immunization with NP-OVA in alum.
(C) Bcl6yfp/+ or Bcl6+/+ OT-II T cells were transferred to CD45.1 recipients that were immunized with OVA in alum and sacrificed 10 days after immunization.
Draining LN sections were stained with anti-GFP to detect YFP-Bcl6, for IgD to demarcate GCs, for CD45.2 to identify OT-II T cells, and with DAPI for cell nuclei.
Scale bars represent 50 mm (left panels) and 5 mm (right panels).
Immunity
Bcl6 Protein Dynamics during the Antibody ResponseTfh cells and Bcl6yfp/+ Tfh cells confirmed the preferential
expression of CD127 in Bcl6-low Tfh cells (Figure 7B). Surface
expression of CCR7 was similarly low between YFP+ Tfh cells
and YFP Tfh cells despite the difference in transcript expres-
sion (Figure S7B). We also cultured these sorted Tfh cell types
in the presence of phorbol ester and ionomycin and found that
the both Tfh cell types were similarly capable of secreting IL-4
(data not shown). Lastly, we examined whether YFP+ and YFP-
Tfh cells were both present in the GC. Immunofluorescence
staining of Bcl6yfp/+ OT-II T cells in the recipient LNs showed
that there were both YFP+ and YFP OT-II T cells in the GC (Fig-
ure 7C). Various magnitudes of Bcl6 expression were also
observed for Bcl6+/+ OT-II T cells in GCs by staining with anti-
Bcl6 (Figure S7C). Taken together, these results suggest that
after downmodulation of Bcl6 protein Tfh cells still reside in the
GC and remain capable of supporting the B cell response and
that these cells rapidly decrease proliferation and gradually
enhance their IL-7 responsiveness and migration potential
including that for egress from the LN to circulation.
DISCUSSION
The regulation of Bcl6 expression in B cells, T cells, and other
immune cells is crucial for successful immune responses, and
its dysregulation can lead to inflammatory diseases andlymphoma development (Klein and Dalla-Favera, 2008; Shaffer
et al., 2001). Bcl6 expression is known to be controlled by the
various posttranscriptional mechanisms (Basso and Dalla-
Favera, 2010; Crotty et al., 2010). Thus, it has been recognized
that detection of Bcl6 protein rather thanBcl6mRNA is important
for understanding the Bcl6-dependent cellular functions. The
present study describes the tracking of Bcl6 protein expression
in individual Ag-engaged B cells and helper T cells during Ab
responses, which was facilitated by the Bcl6 reporter mouse
whose Bcl6 gene locus encodes YFP-Bcl6 fusion protein.
A concern with this reporter animal was that the fusion protein
might display altered stability compared to that of wild-type Bcl6
protein. However, Bcl6yfp/+ GC B cells or Bcl6yfp/+ Tfh cells ex-
pressed YFP-Bcl6 in similar amounts to wild-type Bcl6, suggest-
ing thatYFP-Bcl6 servesas the reporter forwild-typeBcl6 expres-
sion in cells from heterozygous animals. Intracellular Bcl6 staining
of Bcl6yfp/+ GC B cells and Tfh cells further confirmed this view.
However, analysis of cells from homozygous animals indicated
that YFP-Bcl6 was functionally compromised, possibly because
fusionwith YFP near the BTB domain of Bcl6might impair recruit-
ment of thecorepressormoleculesordisrupt the formationofBcl6
homodimers or heterodimers with other BTB domain-containing
transcription factors (Basso and Dalla-Favera, 2010).
Multidirectional differentiation of Ag-engaged B cells sets up
the rapid Ab production by extrafollicular plasma cells and theImmunity 34, 961–972, June 24, 2011 ª2011 Elsevier Inc. 969
Immunity
Bcl6 Protein Dynamics during the Antibody Responsesustained, high-affinity Ab response by GC B cells. It is currently
unknown how B cell commitment to GC B cell differentiation
versus extrafollicular plasmablast differentiation is determined.
The recent discovery by two groups that EBI-2 is important for
localization of Ag-engaged B cells in the outer follicle and for
the development of extrafollicular plasma cells suggests that
the outer follicle is the important site for commitment into the
plasma cell pathway (Gatto et al., 2009; Pereira et al., 2009).
The same groups have also reported that downregulation of
EBI-2 in GC B cells, which is most likely achieved by the Bcl6-
dependent repression, plays a role in their clustering within the
inner follicle (Gatto et al., 2009; Pereira et al., 2009). There was
an uncertainty, however, regarding where the commitment to
GC B cell differentiation takes place because it was still possible
that some Ag-engaged B cells might briefly access the inner
follicle to upregulate Bcl6 for the retention in the region. Our
finding that Bcl6 is upregulated in Ag-engaged B cells in the
outer follicle prior to GC clustering strongly suggests that the
GC commitment occurs in the outer follicle region. Moreover,
B cells defective in developing a Bcl6-high population showed
impaired entry into the GC cluster, suggesting that EBI-2 down-
regulation and other Bcl6-dependent changes in responsiveness
to spatial cues begin in pre-GC B cells while they are still in the
outer follicle. In fact, downregulation of Gpr183 expression was
observed for Bcl6yfp/+ MD4 B cells, but not for Bcl6yfp/yfp MD4
B cells, at this early time point when majority of them are still in
the outer follicle. CXCR4 upregulation was also impaired in
Bcl6yfp/yfp MD4 B cells. It has been reported that CXCR4-defi-
cient GC B cells are able to form clusters in the inner follicle,
although they are defective in the dark-zone/light-zone separa-
tion within GCs (Allen et al., 2004). Therefore, this effect is prob-
ably not the primary cause of the impairment in initial GC entry of
Bcl6yfp/yfp B cells. Nonetheless, it is not excluded that CXCR4
upregulation may play a minor but overlapping role with EBI-2
downregulation. Bcl6 upregulation is most likely important for
retention in the GC as well, although our analysis did not allow
us to conclude on this point. It is also worth mentioning that
the inability of Bcl6yfp/yfp B cells to accumulate in GC clusters
may lead to their failure to receive survival signals and may
contribute to the augmented rate of their death.
At the time when B cells start upregulating Bcl6 in the outer
follicle, the frequency of sustained cognate B-T cell interactions
is decreased compared to earlier time points. Later in themature
GC, the frequency of sustained cognate interactions between
GC B cells and GC Tfh cells is further decreased (Allen et al.,
2007b). Unexpectedly, our results suggest that Bcl6 upregula-
tion in Ag-engaged B cells has a positive effect for sustaining
their conjugation with helper T cells. The SLAM family proteins,
CD84 and Ly106, might be the attractive candidate molecules
responsible for this effect of Bcl6 upregulation since these mole-
cules have been reported to be important for the stable B-T
conjugations, especially for those lasting more than 15 min
(Cannons et al., 2010). However, the decreased frequency was
similarly observed between conjugations tracked for 6–15 min
and those longer than 15 min when B cells were defective in up-
regulation and function of Bcl6. Therefore, it seems more likely
that Bcl6 upregulation enhance integrin-dependent conjugation
of B cells and helper T cells (Cannons et al., 2010). Bcl6 expres-
sion can also regulate costimulatory signals that may affect B-T970 Immunity 34, 961–972, June 24, 2011 ª2011 Elsevier Inc.interaction dynamics. Alternatively, Bcl6 expression may
enhance Ag-presentation by B cells to facilitate cognate interac-
tions with helper T cells. Future studies will be needed to clarify
molecular mechanisms and physiological roles for Bcl6-depen-
dent enhancement of B-T conjugations.
Bcl6 protein expression in CD4+ T cells seems to bewell corre-
lated with Bcl6mRNA expression in the course of Tfh cell devel-
opment. It has been reported thatBcl6mRNAcanbepartially up-
regulated in Ag-engaged CD4+ T cells in the absence of B cells,
although these CD4+ T cells do not develop into Tfh cells (Poho-
lek et al., 2010). Our results show that Bcl6 protein is also partially
upregulated in Ag-engaged CD4+ T cells in the absence of B
cells. CD4+ T cells further upregulate Bcl6 expression to become
Tfh cells usually through cognate interactions with B cells (Crotty
et al., 2010; Deenick et al., 2010; Poholek et al., 2010), and this is
also consistent with our analysis with the YFP-Bcl6 mouse.
Unexpectedly, however, our results suggest that many Tfh cells
start to decrease Bcl6 protein expression before or around the
time of mature GC formation, and almost all the antigen-specific
Tfh cells downmodulate Bcl6 at the later time point. The reduc-
tion of Bcl6 protein expression might not accompany a matched
loss of transcript expression. Future studies need to address
whether posttranscriptional mechanisms operate for regulating
Bcl6 protein expression in these cells.
Amarked phenotype of Bcl6-low Tfh cells was the accelerated
termination of proliferation, while they seemed to remain capable
of providing help to B cells in terms of cytokine expression and
their appearance in the GC. The rapid termination of proliferation
most likely contributes to limiting the number of Tfh cells for
selection of GC B cells (Allen et al., 2007a; Victora et al., 2010)
and preventing dysregulated GC expansion that may cause the
autoimmune diseases (Vinuesa et al., 2009). Because Bcl6 func-
tion has been implicated in cellular proliferation, it is proposed
that the enhanced quiescence of YFP Tfh cells is a result of
the reduction of Bcl6 protein expression. However, our results
may not fit the manner in which Bcl6 has been reported to
promote cellular proliferation. A known target gene of Bcl6-
dependent repression pertaining to GC B cell proliferation is
Cdkn1b encoding a cell cycle inhibitor p27kip1 (Basso and
Dalla-Favera, 2010). However, we did not see upregulation of
Cdkn1b transcripts in YFP Tfh cells. Yet, we detected in these
cells downregulation of many genes whose upregulation is asso-
ciated with cell cycle progression. One of them was Chek1
involved in the DNA-damage response. In proliferating GC B
cells, on the contrary, Bcl6 is thought to repress Chek1 to facili-
tate somatic mutations in the immunoglobulin genes (Basso and
Dalla-Favera, 2010). Thus, cell cycle-related gene targets of
Bcl6 in Tfh cells are not completely overlapped with those in
GC B cells.
It was recently observed that a small fraction of Tfh cells in
GCs expressed IFN-g after Leishmania major infection (Rein-
hardt et al., 2009) and that lymphocytic choriomeningitis virus-
specific Tfh cells expressed T-bet and IFN-g (Johnston et al.,
2009). In addition, it was reported that in the autoimmune condi-
tions GC Tfh cells produced IL-17 (Bauquet et al., 2009; Hsu
et al., 2008). Because Bcl6 was reported to inhibit T-bet and
RORgt expression and/or function (Linterman and Vinuesa,
2010; Nurieva et al., 2009; Yu et al., 2009), it seemed possible
that YFP Tfh cells might upregulate expression of the
Immunity
Bcl6 Protein Dynamics during the Antibody Responsetranscription factors and/or cytokines of Th1 and Th17 cells.
However, this was not the case at least in our immunization
setting using the model Ags. Future studies will need to address
whether YFP Tfh cells are able to acquire Th1 and Th17 effector
functions in response to pathogens or in autoimmune conditions.
The transcription factor Blimp-1 has been suggested to be
important for homeostasis of effector helper T cells other than
Tfh cells (Crotty et al., 2010; Martins and Calame, 2008; Nutt
et al., 2007). Prdm1 expression, which can be repressed by
Bcl6, was also kept low in Bcl6-low Tfh cells. This is consistent
with the observation that Bcl6 transcript was still abundant in
these cells, given that Blimp-1 is known to inhibit Bcl6 expres-
sion (Crotty et al., 2010; Martins and Calame, 2008). Repression
of Prdm-1 expression after the reduction of Bcl6 protein may
involve other transcription factors including Bach2 (Martins and
Calame, 2008).
Our results suggest that almost all of the Ag-specific Tfh cells
become Bcl6 low after weeks of immunization. Because the
Bcl6-low Tfh cells are cell cycle quiescent and express IL-7
receptor, we propose that these cells are precursors of memory
helper T cells derived from Tfh cells. CXCR5+ memory helper
T cells that are resident in draining LNs have been observed in
the late phase of the polyclonal helper T cell response (Fazilleau
et al., 2007). ThesememoryTfh cells have decreasedTfh cytokine
mRNA expression and differ fromBcl6-low Tfh cells in this sense.
Because it is highly possible that Bcl6-low Tfh cells are still in the
course of changing gene expression, these cells may become
more resembled to the LN resident memory Tfh cells at later
time points. Nonetheless, Bcl6-low Tfh cells may be also forming
a distinct subset ofmemory helper T cells because they (or a frac-
tion of them) upregulate Klf2 and S1pr1 expression, which may
allow themtoeventuallyexit fromtheLN (Carlsonetal., 2006;Cys-
ter, 2005) to become recirculating CXCR5+ helper T cells (Fo¨rster
et al., 1994;Morita et al., 2011; Simpson et al., 2010) or to reside in
other tissues like the bone marrow (Tokoyoda et al., 2009).EXPERIMENTAL PROCEDURES
Mice
Mice were housed under specific pathogen-free conditions and used accord-
ing to the guidelines of the RIKEN Animal Research Committee. The Bcl6yfp
mouse generation and the other mice are described in the Supplemental
Information.Cell Isolation, Adoptive Transfer, and Immunization
Preparation of B cells and CD4+ T cells are described in the Supplemental
Information. In most experiments 1 to 5 3 105 Ag-specific B and T cells and
1 to 3 3 107 polyclonal B cells were transferred intravenously. In the experi-
ment in Figure S5D, mice received 1 3 106 MD4 B cells of each genotype
and 2 3 106 OT-II T cells. The mice were then immunized s.c. in the footpad,
the base of the tail, the flank, and the scruff with 15 mg of OVA (Sigma-Aldrich),
NP(13)-OVA (Bioresearch Technologies), or HEL-OVA mixed in alum (Thermo)
or complete Freund’s adjuvant (CFA, Sigma-Aldrich) per site unless otherwise
indicated. For inducing thymus-independent Ab responses, NP(28)-Ficoll
(Bioresearch Technologies) was i.p. injected.Flow Cytometry and Cell Sorting
Cells were resuspended in PBS containing 2% FBS, 2 mM EDTA, and 0.05%
NaN3, stained with Abs, and analyzed on FACSCanto II (BD Biosciences). LN
cells magnetically depleted of non-B cells or non-CD4+ cells were sorted by
FACSAria (BD Biosciences). The other information including those on theAbs and DNA content analysis are described in the Supplemental Information.
Data were analyzed with FlowJo software (Tree Star, Inc.).
Immunofluorescence Microscopy
LNs were placed in Tissue-Tek OCT compound (Sakura) and ‘‘snap-frozen’’ in
dry ice and ethanol. Cryostat sections (8 mm in thickness) were affixed toMAS-
GP-coated slides (Matsunami Glass) and fixed in cold acetone for 10 min. The
reagents used for staining LN sections are described in the Supplemental
Information. Images were acquired on an epifluorescence microscope BZ-
9000 (Keyence).
Two-Photon Microscopy and Image Analysis
Explanted LNs were prepared for imaging as previously described (Allen et al.,
2007b). Imaging was performed with the TCS SP5 upright microscope (Leica
Microsystems) equipped with the Leica 203/1.00 NA water immersion objec-
tive or a BX61/FV1000 upright microscope (Olympus) equipped with an
Olympus 203/0.95 NA water immersion objective. Multiphoton excitation
was provided by a Mai Tai HP Ti:Sapphire laser (Spectra Physics) tuned to
900 nm. The other information on the microscopes and image analysis are in
the Supplemental Information.
Microarray Analysis, Quantitative RT-PCR, ELISA, Immunoblotting,
and Statistical Analysis
Procedures for these analyses are described in the Supplemental Information.
ACCESSION NUMBERS
All microarray data are available in the Gene Expression Omnibus (GEO) data-
base (http://www.ncbi.nlm.nih.gov/gds) under the accession number
GSE24574.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, one table, Supplemental
Experimental Procedures, and five movies and can be found with this article
online at doi:10.1016/j.immuni.2011.03.025.
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